Disputes between 340B Drug Pricing Program-covered entities and the drug manufacturers required to sell outpatient drugs to those entities at discounted prices will be governed by an alternative ...

HHS has finalized a rule to establish a 340B administrative dispute resolution process as required under the Affordable Care Act. The ADR process allows all 340B-covered entities — regardless of the ...

Through its Health Resources and Services Administration, the U.S. Department of Health and Human Services on Nov. 29, 2022, issued a proposed rulemaking that would drastically overhaul the 340B Drug ...

The Biden administration has put the finishing touches on the steps entities covered under the 340B Drug Discount Program must take to resolve disputes with drug manufacturers. The final rule, issued ...